Fulcrum Therapeutics (FULC) Assets Average: 2019-2025
Historic Assets Average for Fulcrum Therapeutics (FULC) over the last 6 years, with Sep 2025 value amounting to $221.8 million.
- Fulcrum Therapeutics' Assets Average fell 22.60% to $221.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.8 million, marking a year-over-year decrease of 22.60%. This contributed to the annual value of $259.2 million for FY2024, which is 7.03% up from last year.
- Fulcrum Therapeutics' Assets Average amounted to $221.8 million in Q3 2025, which was down 5.89% from $235.7 million recorded in Q2 2025.
- Fulcrum Therapeutics' Assets Average's 5-year high stood at $310.7 million during Q2 2023, with a 5-year trough of $143.0 million in Q1 2021.
- Moreover, its 3-year median value for Assets Average was $268.3 million (2023), whereas its average is $265.2 million.
- Per our database at Business Quant, Fulcrum Therapeutics' Assets Average spiked by 80.49% in 2021 and then decreased by 22.60% in 2025.
- Over the past 5 years, Fulcrum Therapeutics' Assets Average (Quarterly) stood at $245.3 million in 2021, then decreased by 3.27% to $237.2 million in 2022, then increased by 13.08% to $268.3 million in 2023, then rose by 0.59% to $269.9 million in 2024, then dropped by 22.60% to $221.8 million in 2025.
- Its last three reported values are $221.8 million in Q3 2025, $235.7 million for Q2 2025, and $251.7 million during Q1 2025.